34 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
by, and delivered their report thereon in compliance with, the Securities Act and the Public Company Accounting Oversight Board (United States) (“PCAOB
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the Chairman can focus on leading the Board in its fundamental role of providing advice to and independent oversight of management. Specifically, the Chair … director due to her employment as Chief Executive Officer of the Company.
Board Oversight of Risk Management
Our management is primarily responsible
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission and/or the competent … applicable regulatory authorities’ legal requirements, regulations and guidelines, and remain subject to oversight by these governmental agencies and ethics
F-3/A
kza807
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
9zvhq
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
flqwwsqjj wceond
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
ib07 sfibxrn4o
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-1.1
fjkpg5ff k3hhocb
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
424B5
af4 5vy8b4
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
3npfoa 4z2
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
6lumhr9hipbq 1vd
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
EX-1.2
r137nq a0
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
b4jigs 0iv38
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
qetqibsmm5yl3 c0l2t9
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
ar69m0
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm